XML 37 R7.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONDENSED STATEMENTS OF CASH FLOWS (USD $)
3 Months Ended 131 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Mar. 31, 2013
Cash flow from operating activities:      
Net loss $ (2,101,525) $ (713,367) $ (21,392,636)
Adjustments to reconcile net loss to net cash used in operating activities:      
Depreciation and amortization 311 147 10,955
Vested stock options and warrants 1,329,735 60,463 4,827,407
Equity instruments issued for management and consulting 67,230 319,500 5,856,998
Stock-based registration payments 0 0 355,124
Capital contributions resulting from waivers of debt 0 0 476,398
Amortization of debt discount 28,521 21,773 371,823
Loss (gain) on valuation of equity-linked financial instruments (19,422) (650) (647,492)
Changes in assets and liabilities:      
Accounts receivable (57,001) 31,225 (96,712)
Inventories 3,762 5,668 (141,447)
Prepaid expense and other assets (28,600) (32,133) (56,009)
Notes payable to shareholders 0 0 (14,957)
Accounts payable (77,831) (2,845) 1,641,008
Accrued expenses (100,465) 59,970 1,617,224
Deferred Revenue 15,000 0 15,000
Net cash used in operating activities: (940,285) (250,249) (7,177,816)
Cash flow from investing activities:      
Purchase of fixed assets 0 0 (12,258)
Purchase of intangibles 0 0 (142,495)
Net cash used in investing activities 0 0 (154,753)
Cash flow from financing activities:      
Proceeds from long-term and convertible debt 300,000 149,657 2,412,491
Repayment of convertible debt   0 (250,000)
Principal payments on long-term debt   0 (75,667)
Issuance of common stock 1,000,000 0 5,618,599
Net cash provided by (used in) financing activities 1,300,000 149,657 7,705,423
Net increase (decrease) in cash 359,715 (100,592) 372,854
Cash at beginning of period 13,139 122,985 0
Cash at end of period 372,854 22,393 372,854
Non cash transactions:      
Conversion of debt to accrued liabilities 415,775   515,775
Common stock issued for accrued interest/bonus 12,225 0 230,395
Conversion of accounts payable to convertible debt 0 0 546,600
Common stock issued to satisfy debt 22,325 83,500 1,064,124
Stock/warrant issued to satisfy accounts payable/Liabilities $ 43,521 $ 0 $ 482,165